Renal Function and Patient-Reported Outcomes in Stable Kidney Transplant Patients Following Conversion From Twice-Daily Immediate-Release Tacrolimus to Once-Daily Prolonged-Release Tacrolimus: A 12-Month Observational Study in Routine Clinical Practice in Germany (ADAGIO)
Author:
Funder
Astellas Pharma
Roche
Vifor Pharma
Sanofi
Pfizer
Bristol-Myers Squibb Canada
Novartis Pharma
Alexion Pharmaceuticals
Chiesi Farmaceutici
Publisher
Elsevier BV
Subject
Transplantation,Surgery
Reference30 articles.
1. Kidney graft survival in Europe and the United States: strikingly different long-term outcomes;Gondos;Transplantation,2013
2. Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus;Kramer;Clin Kidney J,2016
3. Patient-reported non-adherence and immunosuppressant trough levels are associated with rejection after renal transplantation;Scheel;BMC Nephrol,2017
4. Renal function and safety in stable kidney transplant recipients converted from immediate-release to prolonged-release tacrolimus;Lauzurica;Transpl Int,2012
5. Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study;Krämer;Am J Transplant,2010
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The association between tacrolimus exposure and tremor, headache and insomnia in adult kidney transplant recipients: A systematic review;Transplantation Reviews;2024-01
2. The effect of tacrolimus conversion from immediate- to extended-release formulation on renal function in renal transplant patients: a meta-analysis;Frontiers in Pharmacology;2023-10-04
3. Bioética en pacientes renales crónicos avanzados con terapias de soporte renal sustitutivo: hemodiálisis, diálisis peritoneal y trasplantes;Acta Colombiana de Cuidado Intensivo;2023-09
4. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA;Dermatology and Therapy;2023-03-16
5. Outcomes in kidney transplant recipients treated with immediate‐release tacrolimus capsules versus extended‐release tacrolimus capsules: A cohort study;Clinical Transplantation;2022-11-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3